Hemophilia A secondary prevention

Hemophilia A Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemophilia A from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemophilia A secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemophilia A secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemophilia A secondary prevention
CDC on Hemophilia A secondary prevention
Hemophilia A secondary prevention in the news
Blogs on Hemophilia A secondary prevention
Directions to Hospitals Treating Hemophilia A
Risk calculators and risk factors for Hemophilia A secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Secondary Prevention

• Secondary prevention for hemophilia A is aimed at preventing spontaneous or excessive bleeds in patients who are high risk. Patients should be counseled on safe practices and should routine accident prevention.
• Patients with moderate-to-severe hemophilia may be managed with prophylactic transfusions of recombinant clotting factor VIII in order to prevent bleeding episodes.
• Routine prophylactic transfusions are not recommended for patients with mild hemophilia.